1-6 of 6
Authors: Vicente Santa Maria Lopez
Journal Article
ACCEPTED MANUSCRIPT
Salvage therapies for first relapse of SHH medulloblastoma in early childhood
Neuro-Oncology, noaf092, https://doi.org/10.1093/neuonc/noaf092
Published: 04 April 2025
Journal Article
MDB-09. WNT AND GROUP 4 MEDULLOBLASTOMAS OF EARLY CHILDHOOD TREATED WITH HIGH DOSE CHEMOTHERAPY AND CRANIOSPINAL IRRADIATION SPARING APPROACH
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.458
Published: 18 June 2024
Journal Article
MEDB-77. Metastasic medulloblastoma: radiological features and its correlation with molecular subgroups and dissemination pattern
Neuro-Oncology, Volume 24, Issue Supplement_1, June 2022, Page i124, https://doi.org/10.1093/neuonc/noac079.451
Published: 03 June 2022
Journal Article
ATRT-05. Infants and newborns with atypical teratoid/rhabdoid tumors (ATRT) and extracranial malignant rhabdoid tumors: a unique and challenging population
Neuro-Oncology, Volume 24, Issue Supplement_1, June 2022, Pages i2–i3, https://doi.org/10.1093/neuonc/noac079.004
Published: 03 June 2022
Journal Article
IMMU-22. PHASE IB IMMUNOTHERAPY CLINICAL TRIAL WITH THE USE OF AUTOLOGOUS DENDRITIC CELLS PULSED WITH AN ALLOGENIC TUMORAL CELL LINES LYSATE IN PATIENTS WITH NEWLY DIAGNOSED DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)
Neuro-Oncology, Volume 22, Issue Supplement_3, December 2020, Page iii364, https://doi.org/10.1093/neuonc/noaa222.378
Published: 04 December 2020
Journal Article
DIPG-18. IMMUNE RESPONSE GENERATED WITH THE USE OF AUTOLOGOUS DENDRITIC CELLS PULSED WITH AN ALLOGENIC TUMORAL CELL LINES LYSATE IN PATIENTS WITH NEWLY DIAGNOSED DIPG
Neuro-Oncology, Volume 20, Issue suppl_2, June 2018, Page i52, https://doi.org/10.1093/neuonc/noy059.111
Published: 22 June 2018
